The discipline of neurotheranostics was forged to improve diagnostic and therapeutic
clinical outcomes for neurological disorders. Research was facilitated, in largest measure …

The recent progress in biomaterials science and development of tubular conduits (TCs) still
fails in solving the current challenges in the treatment of peripheral nerve injuries (PNIs), in …

Neuroinflammation, mediated by activated microglia and astrocytes, plays a key role in the
pathogenesis of many neurological disorders. Systemically-administered dendrimers target …

Abstract Treatment of Central Nervous System (CNS) disorders still remains a major clinical
challenge. The Blood–Brain Barrier (BBB), known as the major hindrance, greatly limits …

A multivalent phosphorus dendrimer 1G 3 and its corresponding Cu-complex, 1G 3-Cu have
been recently identified as agents retaining high antiproliferative potency. This …

For several decades, the treatment of central nervous system (CNS) disorders such as, for
instance, Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease …

Among the different types of dendrimers, those that incorporate phosphorus in various
positions in their structures present fascinating properties and have wide applications in …

Restrained drug delivery due to the blood–brain barrier (BBB) considerably limits options for
the treatment of brain pathologies. The utilization of nanoparticulate (NP) carriers has been …

Purpose Existing anti-epileptic drugs (AED) have limited efficiency in many patients,
necessitating the search for alternative approaches such as stem cell therapy. We report the …

Dendrimers have emerged as a powerful class of nanomaterials in the nanomedicine field
due to their unique structural features: globular, well‐defined, highly branched and …